Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries. Cain, L. E.; Phillips, A.; Olson, A.; Sabin, C.; Jose, S.; Justice, A.; Tate, J.; Logan, R.; Robins, J. M.; Sterne, J. A.; van Sighem, A.; Reiss, P.; Young, J.; Fehr, J.; Touloumi, G.; Paparizos, V.; Esteve, A.; Casabona, J.; Monge, S.; Moreno, S.; Seng, R.; Meyer, L.; Pérez-Hoyos, S.; Muga, R.; Dabis, F.; Vandenhende, M. A.; Abgrall, S.; Costagliola, D.; Hernán, M. A.. Clin. Infect. Dis.. 2015; 1262-8: p.1262-8. doi:10.1093/cid/ciu1167 10.1093/cid/ciu1167. Epub 2015 Jan 6.

Article